Edwards Lifesciences Corporation Share Price
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
Pre-market 04:31:48 am | |||
| 90.46 USD | -0.79% |
|
88.88 | -1.75% |
| 30/06 | BTIG Adjusts Price Target on Edwards Lifesciences to $110 From $100, Maintains Buy Rating | MT |
| 30/06 | Edwards Lifesciences Secures US FDA Approval for Ecliptis System | MT |
| Market Cap | 5.21TCr 4.56TCr 4.21TCr 3.93TCr 7.39TCr 4,93000Cr 7.53TCr 50TCr 20TCr 2,43000Cr 20TCr 19TCr 8,47000Cr | P/E 2026 * |
32.3x | P/E 2027 * | 27.6x |
|---|---|---|---|---|---|
| Enterprise Value | 4.86TCr 4.26TCr 3.93TCr 3.67TCr 6.9TCr 4,60000Cr 7.03TCr 47TCr 18TCr 2,26700Cr 18TCr 18TCr 7,90300Cr | EV / Sales 2026 * |
7.2x | EV / Sales 2027 * | 6.34x |
| Free-Float |
87.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | -0.79% | ||
| 1 week | +5.33% | ||
| Current month | +4.61% | ||
| 1 month | +4.61% | ||
| 3 months | +14.02% | ||
| 6 months | +4.05% | ||
| Current year | +6.11% |
| 1 week | 87 |  | 92.88 |
| 1 month | 83.17 | | 92.88 |
| Current year | 74.66 | | 92.88 |
| 1 year | 72.3 | | 92.88 |
| 3 years | 58.93 | | 96.12 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/06 | Sell | Chief Executive Officer | -523 | 0.0001% | ||
| 29/05 | Sell | Controller/Auditor | -568 | 0.0001% | ||
| 27/05 | Sell | Executive/Senior Manager | -23,145 | 0.0040% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.79% | +5.33% | +15.66% | -1.70% | 5.25TCr | |
| -1.00% | +8.05% | +22.80% | -2.53% | 19TCr | |
| -2.04% | -1.31% | -25.49% | +17.49% | 14TCr | |
| -1.19% | +6.90% | -4.19% | -19.89% | 14TCr | |
| -1.84% | -3.72% | -59.94% | -19.91% | 6.46TCr | |
| +0.41% | -0.87% | -27.08% | -32.38% | 4.34TCr | |
| +0.19% | +5.01% | +11.46% | +12.52% | 3.75TCr | |
| +1.67% | +4.69% | +6.42% | +43.17% | 3.62TCr | |
| -1.60% | +5.56% | -13.94% | -18.65% | 2.96TCr | |
| -1.79% | +3.41% | -23.62% | -9.87% | 2.87TCr | |
| Average | -0.60% | +4.55% | -9.79% | -3.18% | 7.61TCr | |
| Weighted average by Cap. | -0.71% | +5.66% | -6.04% | -2.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 674.8Cr 590.88Cr 545.44Cr 508.97Cr 957.54Cr 64TCr 975.58Cr 6.54TCr 2.54TCr 31TCr 2.54TCr 2.48TCr 1,09700Cr | 741.05Cr 648.89Cr 598.99Cr 558.93Cr 1.05TCr 70TCr 1.07TCr 7.18TCr 2.79TCr 35TCr 2.78TCr 2.72TCr 1,20500Cr |
| Net income | 162.43Cr 142.23Cr 131.29Cr 122.51Cr 230.49Cr 15TCr 234.83Cr 1.57TCr 610.88Cr 7.58TCr 610.25Cr 596.52Cr 26TCr | 189.11Cr 165.59Cr 152.86Cr 142.64Cr 268.35Cr 18TCr 273.41Cr 1.83TCr 711.23Cr 8.82TCr 710.5Cr 694.52Cr 31TCr |
| Net Debt | -348.23Cr -304.93Cr -281.48Cr -262.65Cr -494.14Cr -33TCr -503.45Cr -3.38TCr -1.31TCr -16TCr -1.31TCr -1.28TCr -57TCr | -507.26Cr -444.18Cr -410.02Cr -382.6Cr -719.8Cr -48TCr -733.36Cr -4.92TCr -1.91TCr -24TCr -1.91TCr -1.86TCr -82TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $90.46 | -0.79% | 35,80,744 |
| 29/26/29 | $91.18 | +0.44% | 36,06,384 |
| 26/26/26 | $90.78 | +1.18% | 1,44,20,825 |
| 25/26/25 | $89.72 | +0.07% | 43,18,766 |
| 24/26/24 | $89.66 | +3.12% | 45,11,691 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
